Close Menu

KRAS Biomarkers

News and reporting on KRAS biomarkers.

Trovagene, MD Anderson Collaborate to ID KRAS Mutations in Pancreatic Cancer Patients' Urine

Two studies published earlier this month in Nature have demonstrated how Inostics' BEAMing digital PCR/flow cytometry technology can be used to detect drug resistance mediated by KRAS mutations in colorectal cancer patients months before treatment failure is observed.

This article has been updated from a previous version to correct the list price of the QX100 system.

A new assay dubbed Allele Specific Locked Nucleic Acid quantitative PCR, or ASLNAqPCR, can identify and quantitate KRAS and BRAF mutations from a variety of sample types with 100 percent specificity, and greater accuracy and higher analytical sensitivity than Sanger sequencing, a

This article has been updated from a previous version to include information about the current status of Fluidigm's collaboration with Novartis.

After a survey of UK oncologists revealed that access hurdles and high costs associated with biomarker testing are limiting their ability to prescribe personalized treatments, Merck Serono has issued a "call to action" for the government and pharmaceutical industry to work togeth

By Ben Butkus
Life Technologies this week announced the expansion of its TaqMan Mutation Detection Assays based on competitive allele-specific TaqMan, or Cast, PCR technology.

By Ben Butkus
RainDance Technologies has launched its digital PCR platform for applications such as rare allele detection and copy number variation analysis.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.